Informing key biopharmaceutical decisions

Recap's mission is to provide analysis and advice for biopharmaceutical business development. Recap's clients include biotechnology and pharmaceutical companies, universities, investment banking, and venture firms. More than 1,500 organizations utilize Recap's data services.

Originally founded in 1988, and now a part of Thomson Reuters, Recap combines extensive experience with the breadth of Thomson Reuters Life Sciences service offerings creating a powerful combination for clients.

For a full overview of the Recap products and services, go to Products and Advisory Services.